Livemint

Mint Explainer | Why India plans to end double testing for plasma-derived medicines

Draft amendments to the Drugs Rules would remove duplicate viral tests on finished plasma-derived medicines once source plasma is verified as safe, aimed at accelerating production of critical therapies and aligning Indias standards with global pharmacopoeias.